A Win For The Medicines Company
Mon, Nov 25, 2019 at 05:30 PM
The Medicines Company (MDCO:NASDAQ) shot up at $83.8, representing a gain of 22.2%. On Fri 22 Nov 19, MDCO:NASDAQ touched a New 2-Week Intraday High of $71.16. The stock got featured on our News Catalysts scanner on Mon 25 Nov 19 at 02:55 PM in the 'ACQUISITION' category. From Mon 04 Nov 19, the stock recorded 57.14% Up Days and 46.67% Green Days
About The Medicines Company (MDCO:NASDAQ)
The Medicines Co is a pharmaceutical company. It provides transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers. The company's products are Angiomax, Ionsys, Minocin for injection and Orbactiv.
Top 10 Gainers:
- Sorrento Therapeutics, Inc. (SRNE:NASDAQ), 94.38%
- JanOne Inc. (JAN:NASDAQ), 54.51%
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 51.61%
- RAPT Therapeutics, Inc. (RAPT:NASDAQ), 44.25%
- CPI Card Group Inc. (PMTS:NASDAQ), 35.48%
- CBAK Energy Technology, Inc. (CBAT:NASDAQ), 28.98%
- Ideanomics, Inc. (IDEX:NASDAQ), 27.14%
- Marathon Patent Group, Inc. (MARA:NASDAQ), 24.55%
- The Medicines Company (MDCO:NASDAQ), 22.25%
- Neoleukin Therapeutics, Inc. (NLTX:NASDAQ), 22.19%